132 related articles for article (PubMed ID: 26215465)
1. Population data analysis of dissolution time profiles: Assessment of physicochemical properties of the drug, drug particles and the pharmaceutical formulation.
Horkovics-Kovats S; Brunovský P; Pichler A; Bulitta JB
Eur J Pharm Sci; 2015 Oct; 78():245-54. PubMed ID: 26215465
[TBL] [Abstract][Full Text] [Related]
2. Disintegration rate and properties of active pharmaceutical ingredient particles as determined from the dissolution time profile of a pharmaceutical formulation: an inverse problem.
Horkovics-Kovats S
J Pharm Sci; 2014 Feb; 103(2):456-64. PubMed ID: 24338791
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dissolution time profiles: No similarity but where is the difference?
Horkovics-Kovats S
Eur J Pharm Sci; 2018 Aug; 121():9-15. PubMed ID: 29782910
[TBL] [Abstract][Full Text] [Related]
4. A novel approach for predicting the dissolution profiles of pharmaceutical tablets.
Paus R; Hart E; Ji Y
Eur J Pharm Biopharm; 2015 Oct; 96():53-64. PubMed ID: 26170163
[TBL] [Abstract][Full Text] [Related]
5. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
6. Dissolution and coarsening of polydisperse, polymorph drug particles liberated from a disintegrating finished dosage form: Theoretical considerations.
Horkovics-Kovats S
Eur J Pharm Sci; 2016 Aug; 91():265-77. PubMed ID: 27155254
[TBL] [Abstract][Full Text] [Related]
7. A Review of Disintegration Mechanisms and Measurement Techniques.
Markl D; Zeitler JA
Pharm Res; 2017 May; 34(5):890-917. PubMed ID: 28251425
[TBL] [Abstract][Full Text] [Related]
8. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
9. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
Leonardi D; Barrera MG; Lamas MC; Salomón CJ
AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
[TBL] [Abstract][Full Text] [Related]
10. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.
Uebbing L; Klumpp L; Webster GK; Löbenberg R
Drug Des Devel Ther; 2017; 11():1163-1174. PubMed ID: 28442890
[TBL] [Abstract][Full Text] [Related]
11. Analysis of chlorthalidone polymorphs in raw materials and tablets and the effect of forms I and II on the dissolution properties of drug products.
Bonfilio R; Leal JS; Santos OM; Pereira GR; Doriguetto AC; de Araújo MB
J Pharm Biomed Anal; 2014 Jan; 88():562-70. PubMed ID: 24216278
[TBL] [Abstract][Full Text] [Related]
12. Dissolution profiles of drugs from tablets.
Kitamori N; Iga K
J Pharm Sci; 1978 Oct; 67(10):1436-9. PubMed ID: 702298
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the crystalline and amorphous states of drug products by nanothermal analysis and Raman imaging.
Nakamoto K; Urasaki T; Hondo S; Murahashi N; Yonemochi E; Terada K
J Pharm Biomed Anal; 2013 Mar; 75():105-11. PubMed ID: 23246930
[TBL] [Abstract][Full Text] [Related]
14. Dropwise additive manufacturing of pharmaceutical products for solvent-based dosage forms.
Hirshfield L; Giridhar A; Taylor LS; Harris MT; Reklaitis GV
J Pharm Sci; 2014 Feb; 103(2):496-506. PubMed ID: 24311373
[TBL] [Abstract][Full Text] [Related]
15. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
16. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
17. [Simultaneous determination of disintegration and dissolution times of solid drug forms in a rotating flask dissolution tester. "Apparent" and "intrinsic" disintegration time].
Koch HP; Faltis I; Mladenow H
Pharmazie; 1987 Feb; 42(2):90-4. PubMed ID: 3602066
[TBL] [Abstract][Full Text] [Related]
18. Drug dissolution from indomethacin-starch hybrid powders prepared by the dry impact blending method.
Ishizaka T; Honda H; Koishi M
J Pharm Pharmacol; 1993 Sep; 45(9):770-4. PubMed ID: 7903362
[TBL] [Abstract][Full Text] [Related]
19. Influence of process parameters and equipment on dry foam formulation properties using indomethacin as model drug.
Sprunk A; Page S; Kleinebudde P
Int J Pharm; 2013 Oct; 455(1-2):189-96. PubMed ID: 23891743
[TBL] [Abstract][Full Text] [Related]
20. Triboelectrification and dissolution property enhancements of solid dispersions.
Asare-Addo K; Šupuk E; Al-Hamidi H; Owusu-Ware S; Nokhodchi A; Conway BR
Int J Pharm; 2015 May; 485(1-2):306-16. PubMed ID: 25772415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
